|
|
1221 Crossman Ave
Sunnyvale, CA 94089 USA
phone:
(408) 548-6500
fax:
(408) 548-6501 |
| Symbol |
KYPH |
| Exchange |
NASDAQ |
| Founded |
1994 |
| Employees |
700 |
|
|
www.kyphon.com |
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Restoring spinal function through minimally invasive therapies. |
 |
| Management |
| Richard W. Mott, President and Chief Executive Officer; Karen D. Talmadge, Ph.D., Executive Vice President, Co-Founder and Chief Science Officer; Arthur T. Taylor, Vice President, Chief Operating Officer; Maureen L. Lamb, Vice President, Chief Financial Officer and Treasurer; Robert A. Vandervelde, President, International; Bradley W. Paddock, Vice President, US Sales; David M. Shaw, Vice President, Legal Affairs, General Counsel and Secretary; Alexandre M. DiNello, Vice President, Research & Development; Avram A. Edidin, Ph.D., Vice President, Scientific Affairs; Frank P. Grillo, Vice President, Marketing, Strategy & Business Development; Mary K. Hailey, Vice President, Health Care Policy and Government Relations; Stephen C. Hams, Vice President, Human Resources; Robert E. Johnson, Vice President, Chief Compliance Officer; Rick S. Kline, Vice President, Operations; Elizabeth A. Rothwell, Vice President, Quality Assurance and Regulatory Affairs; Julie D. Tracy, Vice President, Chief Communications Officer |
|
|
|
|
| Keywords |
| reconstruction, orthopedics, advamed |
|
|
|
|
Description |
| Kyphon develops and markets medical devices designed to restore spinal anatomy using minimally-invasive technology. The Companyís initial marketing focus is on surgeons who repair spine fractures caused by osteoporosis. Kyphon's first commercial products, are used in Balloon Kyphoplasty, a minimally invasive procedure to repair spinal fractures. Kyphon's instruments provide an alternative to highly invasive spine fracture treatments and pain-management therapies. Kyphon sells its products through a direct sales force in the United States and through a combination of direct representatives and third party distributors internationally. |
 |
| Products / Services |
The Company sells the following instruments for use in spine fracture procedures: Bone Access Systems, Inflatable Bone Tamp, Inflation Syringe, Bone Filler Device and Bone Biopsy Device.
|
 |
| Technology / Differentiation |
| Kyphon's utilizes a minimally invasive technology. Kyphon's first commercial products, comprising its KyphX instruments, utilize its proprietary balloon technology. Surgeons use those tools to help repair fractures during minimally invasive spine surgeries. Its instruments have also been used in open surgical procedures. |
 |
| Market / Customers |
There are 10 million men and women estimated to have osteoporosis. Additionally, there are 1.5 million fragility fractures in the U.S., nearly half of which occur in the spine. The Company's customers are 1300 hospitals.
|
 |
| Competitors / Substitutes / Alternatives |
Aesculap/B.Braun, DePuy Spine, Stryker Spine, RSB Spine, SeaSpine, Blackstone, Signus, Medtronic, Synthes Spine, Theken Spine, Zimmer Spine, Vertebron
|
 |
| Strategy |
Kyphon is building its spinal specialists sales force, going direct to referring MD's and testing direct to consumer marketing efforts in three test markets. It is also building Internationl effort in Germany and Japan by doubling Int'l sales force to 60.
|
 |
| Funding |
| awaiting content update |
 |
| Status |
| Company expects to perform 45,000 cases this year. |
 |
|
Additional Information |
| awaiting content update |
|
|
|
|